LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 179

Search options

  1. Article: Cancer Metabolism: Fasting Reset, the Keto-Paradox and Drugs for Undoing.

    Israël, Maurice / Berg, Eric / Tenenbaum, Guy

    Journal of clinical medicine

    2023  Volume 12, Issue 4

    Abstract: In tumor cells, ketolysis "via" succinyl-CoA: 3-oxoacid-CoAtransferase (SCOT) and acetyl-CoA acetyltransferase 1 (ACAT1) is a major source of mitochondrial acetyl-CoA. Active ACAT1 tetramers stabilize by tyrosine phosphorylation, which facilitates the ... ...

    Abstract In tumor cells, ketolysis "via" succinyl-CoA: 3-oxoacid-CoAtransferase (SCOT) and acetyl-CoA acetyltransferase 1 (ACAT1) is a major source of mitochondrial acetyl-CoA. Active ACAT1 tetramers stabilize by tyrosine phosphorylation, which facilitates the SCOT reaction and ketolysis. Tyrosine phosphorylation of pyruvate kinase PK M2 has the opposite effect, stabilizing inactive dimers, while pyruvate dehydrogenase (PDH), which is already inhibited by phosphorylation, is acetylated by ACAT1 and is doubly locked. This closes the glycolytic supply of acetyl-CoA. In addition, since tumor cells must synthesize fatty acids to create new membranes, they automatically turn off the degradation of fatty acids into acetyl-CoA ("via" the malonyl-CoA brake for the fatty acid carnityl transporter). Thus, inhibiting SCOT the specific ketolytic enzyme and ACAT1 should hold back tumor progression. However, tumor cells are still able to take up external acetate and convert it into acetyl-CoA in their cytosol "via" an acetyl-CoA synthetase, which feeds the lipogenic pathway; additionally, inhibiting this enzyme would make it difficult for tumor cells to form new lipid membrane and survive.
    Language English
    Publishing date 2023-02-17
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2662592-1
    ISSN 2077-0383
    ISSN 2077-0383
    DOI 10.3390/jcm12041589
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Inhibition of the ketolytic acetyl CoA supply to tumors could be their "Achilles heel".

    Israël, Maurice / Schwartz, Laurent

    International journal of cancer

    2020  Volume 147, Issue 6, Page(s) 1755–1757

    MeSH term(s) Acetyl Coenzyme A/metabolism ; Antineoplastic Agents/pharmacology ; Antineoplastic Agents/therapeutic use ; Coenzyme A-Transferases/antagonists & inhibitors ; Coenzyme A-Transferases/metabolism ; Combined Modality Therapy/methods ; Diet, Ketogenic ; Humans ; Liver/cytology ; Liver/metabolism ; Mitochondria/drug effects ; Mitochondria/metabolism ; Neoplasms/metabolism ; Neoplasms/therapy ; Warburg Effect, Oncologic/drug effects
    Chemical Substances Antineoplastic Agents ; Acetyl Coenzyme A (72-89-9) ; Coenzyme A-Transferases (EC 2.8.3.-) ; 3-ketoacid CoA-transferase (EC 2.8.3.5)
    Language English
    Publishing date 2020-03-31
    Publishing country United States
    Document type Letter
    ZDB-ID 218257-9
    ISSN 1097-0215 ; 0020-7136
    ISSN (online) 1097-0215
    ISSN 0020-7136
    DOI 10.1002/ijc.32979
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: Comment on cancer metabolism and on the role of the endocrine pancreas.

    Israel, Maurice

    Journal of clinical medicine research

    2014  Volume 6, Issue 6, Page(s) 490–491

    Language English
    Publishing date 2014-09-09
    Publishing country Canada
    Document type Journal Article
    ZDB-ID 2548987-2
    ISSN 1918-3011 ; 1918-3003
    ISSN (online) 1918-3011
    ISSN 1918-3003
    DOI 10.14740/jocmr1912w
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: An alteration of the endocrine pancreas involved in cancer.

    Israël, Maurice

    Cancer causes & control : CCC

    2014  Volume 25, Issue 12, Page(s) 1733–1736

    Abstract: Tumor cells display hybrid metabolic features: some of their enzymes are phosphorylated as normally observed when catabolic hormones stimulate Gs-coupled receptors, whereas other enzymes adopt a configuration normally found in anabolic situations, ... ...

    Abstract Tumor cells display hybrid metabolic features: some of their enzymes are phosphorylated as normally observed when catabolic hormones stimulate Gs-coupled receptors, whereas other enzymes adopt a configuration normally found in anabolic situations, mediated via tyrosine kinase receptors. Consequently, tumor cells have to rewire their metabolic pathways differently, whereas differentiated cells seem to respond preferentially to catabolic hormones. This gives mitotic cells a selective advantage since they deplete other cell reserves for their benefit. The pancreatic gamma aminobutyric acid selection switch between anabolism and catabolism explains the process, that is, a deficient release of gamma aminobutyric acid from beta cells leads to a concomitant release of catabolic glucagon and anabolic insulin and to a progressive desensitisation of insulin receptors on differentiated cells. New stem cells, with non-desensitised insulin receptors, respond to the dual anabolic and catabolic signals and rewire their metabolism in cancer mode. The aim of this letter was to discuss the causal pancreatic alteration of the anabolic-catabolic selection switch.
    MeSH term(s) Glucagon/metabolism ; Humans ; Insulin/metabolism ; Islets of Langerhans/pathology ; Metabolism ; Pancreatic Neoplasms/pathology
    Chemical Substances Insulin ; Glucagon (9007-92-5)
    Language English
    Publishing date 2014-12
    Publishing country Netherlands
    Document type Letter ; Review
    ZDB-ID 1064022-8
    ISSN 1573-7225 ; 0957-5243
    ISSN (online) 1573-7225
    ISSN 0957-5243
    DOI 10.1007/s10552-014-0477-0
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: A possible primary cause of cancer: deficient cellular interactions in endocrine pancreas.

    Israël, Maurice

    Molecular cancer

    2012  Volume 11, Page(s) 63

    Abstract: Background: Cancer is a devastating type of disease. New and innovative ways to tackle cancers that have so far proved refractive to conventional therapies is urgently needed. It is becoming increasingly clear that, in addition to conventional ... ...

    Abstract Background: Cancer is a devastating type of disease. New and innovative ways to tackle cancers that have so far proved refractive to conventional therapies is urgently needed. It is becoming increasingly clear that, in addition to conventional therapeutics targeting by small molecules, that tumor cell metabolism presents new opportunities to target selectively specific cancer cell populations. Metabolic defects in cancer cells can be manifested in many ways that might not be readily apparent, such as altering epigenetic gene regulation for example. The complex rewiring of metabolic pathways gives tumor cells a special advantage over differentiated cells, since they deplete body stores as fuel for their growth and proliferation. Tumor metabolism looks simpler when we consider that some enzymatic switches are in a neoglucogenic direction thereby depleting body stores. However, these pathways may be inadequately switched on by catabolic hormones (glucagon, epinephrine and cortisol) in a specific situation where anabolism is activated by, for example insulin released from beta pancreatic cells or IGF, inducing mitosis and synthesis that are powered by glucose catabolism. Such a hybrid metabolic situation would be reached if a pancreatic beta cell mechanism, mediated by GABA, failed to silence neighboring alpha cells and delta cells. The inhibitory transmitter GABA hyperpolarizes alpha and delta cells via their GABA A receptors, and blocks the release of glucagon and somatostatin. Alternatively, an anomaly of alpha cell channels, would lead to a similar situation. Whatever is the alteration, anabolism fails to silence catabolism and enzymatic switches controlled by kinases and phosphatases adopt an inadequate direction, leading to a hybrid metabolic rewiring found in cancer. It is daring to formulate such a hypothesis as this. However, it is quite possible that the starting point in cancer is an alteration of the endocrine pancreas, suppressing the mechanism by which beta cells silence the neighboring alpha and delta cells, with GABA and Zn2+.
    MeSH term(s) Blood Glucose ; Cell Communication ; Hormones/metabolism ; Humans ; Ion Channels/metabolism ; Islets of Langerhans/metabolism ; Neoplasms/etiology ; Neoplasms/metabolism
    Chemical Substances Blood Glucose ; Hormones ; Ion Channels
    Language English
    Publishing date 2012-09-06
    Publishing country England
    Document type Journal Article
    ISSN 1476-4598
    ISSN (online) 1476-4598
    DOI 10.1186/1476-4598-11-63
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: Un remède pour les yeux prescrit dans l'Egypte pharaonique.

    Israël, Maurice

    La Revue du praticien

    2009  Volume 59, Issue 10, Page(s) 1472–1477

    Title translation A prescription for the eyes in ancient Egypt.
    MeSH term(s) Drug Prescriptions/history ; Egypt, Ancient ; History, Ancient ; Humans ; Manuscripts as Topic/history ; Ophthalmology/history
    Language French
    Publishing date 2009-12-20
    Publishing country France
    Document type Historical Article ; Journal Article
    ZDB-ID 205365-2
    ISSN 2101-017X ; 0035-2640
    ISSN (online) 2101-017X
    ISSN 0035-2640
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: A possible primary cause of cancer

    Israël Maurice

    Molecular Cancer, Vol 11, Iss 1, p

    deficient cellular interactions in endocrine pancreas

    2012  Volume 63

    Abstract: Abstract Background Cancer is a devastating type of disease. New and innovative ways to tackle cancers that have so far proved refractive to conventional therapies is urgently needed. It is becoming increasingly clear that, in addition to conventional ... ...

    Abstract Abstract Background Cancer is a devastating type of disease. New and innovative ways to tackle cancers that have so far proved refractive to conventional therapies is urgently needed. It is becoming increasingly clear that, in addition to conventional therapeutics targeting by small molecules, that tumor cell metabolism presents new opportunities to target selectively specific cancer cell populations. Metabolic defects in cancer cells can be manifested in many ways that might not be readily apparent, such as altering epigenetic gene regulation for example. The complex rewiring of metabolic pathways gives tumor cells a special advantage over differentiated cells, since they deplete body stores as fuel for their growth and proliferation. Tumor metabolism looks simpler when we consider that some enzymatic switches are in a neoglucogenic direction thereby depleting body stores. However, these pathways may be inadequately switched on by catabolic hormones (glucagon, epinephrine and cortisol) in a specific situation where anabolism is activated by, for example insulin released from beta pancreatic cells or IGF, inducing mitosis and synthesis that are powered by glucose catabolism. Such a hybrid metabolic situation would be reached if a pancreatic beta cell mechanism, mediated by GABA, failed to silence neighboring alpha cells and delta cells. The inhibitory transmitter GABA hyperpolarizes alpha and delta cells via their GABA A receptors, and blocks the release of glucagon and somatostatin. Alternatively, an anomaly of alpha cell channels, would lead to a similar situation. Whatever is the alteration, anabolism fails to silence catabolism and enzymatic switches controlled by kinases and phosphatases adopt an inadequate direction, leading to a hybrid metabolic rewiring found in cancer. It is daring to formulate such a hypothesis as this. However, it is quite possible that the starting point in cancer is an alteration of the endocrine pancreas, suppressing the mechanism by which beta cells silence the neighboring alpha and delta cells, with GABA and Zn 2+ .
    Keywords Neoplasms. Tumors. Oncology. Including cancer and carcinogens ; RC254-282 ; Internal medicine ; RC31-1245 ; Medicine ; R ; DOAJ:Oncology ; DOAJ:Medicine (General) ; DOAJ:Health Sciences
    Subject code 610
    Language English
    Publishing date 2012-09-01T00:00:00Z
    Publisher BioMed Central
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  8. Book ; Online: Les Études et la guerre : Les Normaliens dans la tourmente (1939-1945)

    Israël, Stéphane

    2005  

    Abstract: ... appelés à un brillant avenir y ont fait leurs premières classes universitaires. Pêle-mêle, Maurice Clavel ...

    Abstract Dans les années sombres de la Seconde Guerre mondiale, lÉcole normale supérieure de la rue dUlm a vécu au rythme des événements qui ont boule-versé la France. Sy sont croisées des figures aussi différentes que Jérôme Carcopino - directeur de lÉcole et un temps ministre à Vichy -, Jean Cavaillès - « philosophe bourré dexplosifs » - et Henri Cartan - le père des mathématiques modernes. Des jeunes gens appelés à un brillant avenir y ont fait leurs premières classes universitaires. Pêle-mêle, Maurice Clavel, Jean Delumeau, Pierre Moussa, René Rémond ou Jean-François Revel pour les lettres, Marcel Boiteux, Gérard Debreu ou René Thom pour les sciences. Tandis que les candidats juifs, interdits de scolarité, se voyaient attribuer des numéros « bis » en cas de réussite au concours. Alors les normaliens ont à la fois beaucoup travaillé et, pour certains, beaucoup résisté, surtout après la mise en place du STO en février 1943. Robert Salmon a fondé Défense de la France. Henri Plard a passé trois mois à Drancy pour avoir porté létoile jaune alors quil était protestant. La Gestapo a fait irruption rue dUlm la nuit du 4 août 1944. Elle a arrêté le directeur adjoint Jean Bruhat et le secrétaire général Jean Baillou. Le premier nest jamais revenu de Buchenwald. Soixante ans après, cest cette histoire que retrace Stéphane Israël au terme dune enquête sur les normaliens des promotions 1937 à 1943 et sur ladministration et les enseignants de lÉcole pendant la Seconde Guerre mondiale. Lhistoire totale dun passé qui ne passe pas
    Keywords History (General)
    Size 1 electronic resource ( pages)
    Publisher Éditions Rue d'Ulm
    Document type Book ; Online
    Note French ; Open Access
    HBZ-ID HT020321287
    ISBN 9782821829787 ; 2821829787
    Database ZB MED Catalogue: Medicine, Health, Nutrition, Environment, Agriculture

    More links

    Kategorien

  9. Article: Genetic adaptation controlled by methylations and acetylations at the nuclear and cytosolic levels: a hypothetical model.

    Israël, Maurice

    Neurochemical research

    2003  Volume 28, Issue 3-4, Page(s) 631–635

    Abstract: Metabolic sensors related to the maturation of metabolism seem to control a process of generic adaptation involving the silencing of genes and the expression of their copies more adapted to environmental changes. Nuclear methylases and histone ... ...

    Abstract Metabolic sensors related to the maturation of metabolism seem to control a process of generic adaptation involving the silencing of genes and the expression of their copies more adapted to environmental changes. Nuclear methylases and histone deacetylases control the gene silencing process. Nuclear methylases compete with cytosolic methylases for the same methyl donnors, this will favor the expression of unmethylated more adapted gene copies, when cytosotic methylases take over. Methylated cytosolic compounds may then represent an index of this adaptation. If a more adapted gene copy is mutated, the regulatory ligand of the gene product that does not find its target may induce a reexpression of the silenced gene. The hypothetical model proposed considers that gene silencing and expression of a more adequate copy involves a non-specific gene silencer switch that depends on the histone status; the silencer switch is counteracted by the ligand of the adapted gene copy product acting like an inducer.
    MeSH term(s) Acetylation ; Adaptation, Physiological ; Animals ; Cell Nucleus/physiology ; Cytosol/physiology ; Gene Expression Regulation ; Gene Silencing ; Humans ; Methylation ; Models, Genetic ; Muscular Atrophy, Spinal/genetics ; Muscular Atrophy, Spinal/physiopathology
    Language English
    Publishing date 2003-01-21
    Publishing country United States
    Document type Journal Article
    ZDB-ID 199335-5
    ISSN 1573-6903 ; 0364-3190
    ISSN (online) 1573-6903
    ISSN 0364-3190
    DOI 10.1023/a:1022898029012
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Book: La transmission cholinergique de l'excitation

    Fardeau, Michael / Israel, Maurice

    symp. internat. ... Paris, 2 - 3 juin 1972 = cholinergic Transmission of the nerve Impulse

    (INSERM Colloque ; [10])

    1973  

    Title variant cholinergic Transmission of the nerve Impulse
    Author's details (publ. sous la responsabilité de Michel Fardeau ; Maurice Israel et Robert Manaranche)
    Series title INSERM Colloque ; [10]
    Collection
    Language French
    Size XV, 294 S. ; 4-o
    Publisher Ed. INSERM
    Publishing place Paris
    Publishing country France
    Document type Book
    HBZ-ID HT010131216
    Database Catalogue ZB MED Medicine, Health

    Kategorien

To top